Hill Amanda B T, Murphy Yanet M, Polkoff Kathryn M, Edwards Laura, Walker Derek M, Moatti Adele, Greenbaum Alon, Piedrahita Jorge A
College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States.
Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States.
Front Genome Ed. 2024 Jun 6;6:1401163. doi: 10.3389/fgeed.2024.1401163. eCollection 2024.
Recent advancements in genome editing techniques, notably CRISPR-Cas9 and TALENs, have marked a transformative era in biomedical research, significantly enhancing our understanding of disease mechanisms and helping develop novel therapies. These technologies have been instrumental in creating precise animal models for use in stem cell research and regenerative medicine. For instance, we have developed a transgenic pig model to enable the investigation of LGR5-expressing cells. The model was designed to induce the expression of H2B-GFP under the regulatory control of the LGR5 promoter via CRISPR/Cas9-mediated gene knock-in. Notably, advancements in stem cell research have identified distinct subpopulations of LGR5-expressing cells within adult human, mouse, and pig tissues. LGR5, a leucine-rich repeat-containing G protein-coupled receptor, enhances WNT signaling and these LGR5 subpopulations demonstrate varied roles and anatomical distributions, underscoring the necessity for suitable translational models. This transgenic pig model facilitates the tracking of LGR5-expressing cells and has provided valuable insights into the roles of these cells across different tissues and species. For instance, in pulmonary tissue, Lgr5 cells in mice are predominantly located in alveolar compartments, driving alveolar differentiation of epithelial progenitors via Wnt pathway activation. In contrast, in pigs and humans, these cells are situated in a unique sub-basal position adjacent to the airway epithelium. In fetal stages a pattern of LGR5 expression during lung bud tip formation is evident in humans and pigs but is lacking in mice. Species differences with respect to LGR5 expression have also been observed in the skin, intestines, and cochlea further reinforcing the need for careful selection of appropriate translational animal models. This paper discusses the potential utility of the LGR5 pig model in exploring the role of LGR5 cells in tissue development and regeneration with the goal of translating these findings into human and animal clinical applications.
基因组编辑技术的最新进展,尤其是CRISPR-Cas9和转录激活样效应因子核酸酶(TALENs),标志着生物医学研究进入了一个变革性的时代,极大地增进了我们对疾病机制的理解,并有助于开发新的疗法。这些技术在创建用于干细胞研究和再生医学的精确动物模型方面发挥了重要作用。例如,我们开发了一种转基因猪模型,用于研究表达LGR5的细胞。该模型旨在通过CRISPR/Cas9介导的基因敲入,在LGR5启动子的调控下诱导H2B-GFP的表达。值得注意的是,干细胞研究的进展已经在成人、小鼠和猪的组织中鉴定出表达LGR5的不同亚群细胞。LGR5是一种富含亮氨酸重复序列的G蛋白偶联受体,可增强WNT信号传导,这些LGR5亚群表现出不同的作用和解剖分布,凸显了合适的转化模型的必要性。这种转基因猪模型有助于追踪表达LGR5的细胞,并为这些细胞在不同组织和物种中的作用提供了有价值的见解。例如,在肺组织中,小鼠的Lgr5细胞主要位于肺泡隔中,通过激活Wnt途径驱动上皮祖细胞的肺泡分化。相比之下,在猪和人类中,这些细胞位于与气道上皮相邻的独特基底旁位置。在胎儿阶段,人类和猪在肺芽尖形成过程中存在LGR5表达模式,但小鼠中不存在。在皮肤、肠道和耳蜗中也观察到了LGR5表达的物种差异,进一步强调了仔细选择合适的转化动物模型的必要性。本文讨论了LGR5猪模型在探索LGR5细胞在组织发育和再生中的作用方面的潜在用途,目的是将这些发现转化为人类和动物的临床应用。